Anesthesia Patient Safety Podcast
#233 Revolutionizing Anesthesia: The Impact of Remimazolam
17 Dec 2024
Unlock the future of perioperative medicine with insights into remimazolam, the cutting-edge benzodiazepine poised to transform anesthesia practices. We uncover the remarkable features of remimazolam, from its rapid onset and short duration to its unique reversibility and minimal impact on cardiac and respiratory systems. Discover why this novel sedative is gaining traction for neurosurgery and neurology applications, especially for short procedures in the U.S. market.Explore the nuances of remimazolam's pharmacology, its economic considerations, and how it stands out in complex cardiovascular cases and interventional radiology. With practical insights into its effective use even in MRI procedures for patients with claustrophobia or spinal cord stenosis, this episode is your gateway to understanding how remimazolam is reshaping anesthesia with enhanced patient safety and recovery. This information was previously published in Episodes #175 and #176 and brought together to make one high-yield revisited show all about Remimazolam today.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/233-revolutionizing-anesthesia-the-impact-of-remimazolam/© 2024, The Anesthesia Patient Safety Foundation
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View